Jennifer S Im, MD
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Im’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$2,348
Medicare paid this office $2,348 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 67 · 85 and older 0% · Health risk score 4.52. Sicker patients than 9 in 10 peers; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75%.
The office billed $8,095, Medicare allowed $3,255 and paid $2,348; for 27 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 27 | 67 | 4.52 | $8,095 | $2,348 |
| 2023 | 17 | 29 | 69 | 3.20 | $5,526 | $2,599 |
| 2022 | 54 | 77 | 74 | 3.14 | $28,560 | $9,861 |
| 2021 | 102 | 225 | 76 | 2.53 | $103,980 | $33,920 |
| 2018 | 60 | 74 | 68 | 2.70 | $18,570 | $8,385 |
| 2017 | 51 | 59 | 68 | 3.51 | $15,530 | $6,782 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 2 services
| Critical care, first 30-74 minutes | 20 | $5,259 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,060 | $66 |
2021: 3 services
| Critical care, first 30-74 minutes | 57 | $26,212 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,953 | $66 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $901 | $75 |
2018: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,177 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,025 | $57 |
2017: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,237 | $157 |
Drugs they prescribed that Part D paid
$344,292
Pharmacies billed $344,292 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
571 generic and fewer than 11 brand-name prescriptions · $344,292 in drug cost · 82 antibiotic prescriptions to 54 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 15 | $188,360 | $12,557 |
| Breztri Aerosphere | 48 | $38,015 | $792 |
| Spiriva Respimat | 54 | $30,636 | $567 |
| Breyna | 150 | $17,206 | $115 |
| Trelegy Ellipta | 20 | $14,575 | $729 |
See all 22 drugs
| Ofev | 15 | $188,360 | $12,557 |
| Breztri Aerosphere | 48 | $38,015 | $792 |
| Spiriva Respimat | 54 | $30,636 | $567 |
| Breyna | 150 | $17,206 | $115 |
| Trelegy Ellipta | 20 | $14,575 | $729 |
| Wixela Inhub | 35 | $10,124 | $289 |
| Pirfenidone | 28 | $7,145 | $255 |
| Mycophenolate Mofetil | 34 | $4,462 | $131 |
| Alvesco | 19 | $2,419 | $127 |
| Albuterol Sulfate Hfa | 92 | $1,775 | $19 |
| Levalbuterol Tartrate Hfa | 16 | $1,136 | $71 |
| Prednisone | 92 | $956 | $10 |
| Ventolin Hfa | 12 | $950 | $79 |
| Fluticasone Propionate | 20 | $350 | $18 |
| Pantoprazole | 28 | $261 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $248 | $18 |
| Azelastine | 11 | $186 | $17 |
| Gabapentin | 13 | $173 | $13 |
| Sulfamethoxazole-Trimethoprim | 21 | $148 | $7 |
| Doxycycline Monohydrate | 12 | $128 | $11 |
| Azithromycin | 16 | $118 | $7 |
| Omeprazole | 16 | $107 | $7 |
Year by year
| 2024 | 874 | 222 | None | None | $344,292 |
| 2023 | 482 | 152 | None | None | $224,081 |
| 2022 | 92 | 40 | 0% (0) | 38% | $26,923 |
| 2021 | 90 | 35 | 0% (0) | 59% | $24,397 |
| 2020 | 58 | 22 | 0% (0) | 67% | $17,691 |
| 2019 | 44 | 12 | 0% (0) | 68% | $9,694 |
| 2018 | 28 | None | None | None | $501 |
| 2017 | 402 | 46 | None | 20% | $19,328 |
| 2016 | 557 | 84 | None | None | $28,305 |
| 2015 | 130 | 28 | 0% (0) | None | $13,440 |
| 2014 | 20 | None | 0% (0) | 0% | $205 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Ofev | 16 | $145,091 | $9,068 |
| Spiriva Respimat | 42 | $18,316 | $436 |
| Symbicort | 54 | $15,124 | $280 |
| Wixela Inhub | 29 | $9,163 | $316 |
| Pirfenidone | 21 | $6,069 | $289 |
| Alvesco | 25 | $2,975 | $119 |
| Mycophenolate Mofetil | 14 | $1,764 | $126 |
| Albuterol Sulfate Hfa | 64 | $1,356 | $21 |
| Prednisone | 58 | $697 | $12 |
| Pantoprazole | 13 | $147 | $11 |
| Fluticasone Propionate | 11 | $146 | $13 |
2022: 1 drug
| Albuterol Sulfate Hfa | 14 | $427 | $31 |
2021: 1 drug
| Symbicort | 16 | $7,863 | $491 |
2017: 14 drugs
| Januvia | 13 | $5,141 | $395 |
| Symbicort | 11 | $2,952 | $268 |
| Metoprolol | 20 | $619 | $31 |
| Rosuvastatin | 12 | $370 | $31 |
| Levothyroxine | 19 | $296 | $16 |
| Atorvastatin | 40 | $296 | $7 |
| Nifedipine Er | 13 | $286 | $22 |
| Clopidogrel | 21 | $151 | $7 |
| Lisinopril | 41 | $130 | $3 |
| Gabapentin | 17 | $98 | $6 |
| Omeprazole | 12 | $64 | $5 |
| Metformin | 12 | $62 | $5 |
| Hydrochlorothiazide | 11 | $40 | $4 |
| Amlodipine Besylate | 11 | $19 | $2 |
2016: 13 drugs
| Flovent Hfa | 11 | $3,480 | $316 |
| Metoprolol | 31 | $923 | $30 |
| Ventolin Hfa | 12 | $608 | $51 |
| Atorvastatin | 30 | $221 | $7 |
| Omeprazole | 27 | $156 | $6 |
| Clopidogrel | 20 | $135 | $7 |
| Mirtazapine | 13 | $120 | $9 |
| Losartan | 21 | $106 | $5 |
| Isosorbide Mononitrate Er | 11 | $103 | $9 |
| Pantoprazole | 16 | $101 | $6 |
| Lisinopril | 37 | $94 | $3 |
| Metformin | 13 | $24 | $2 |
| Simvastatin | 11 | $21 | $2 |
Money from drug and device companies
$75 in 2025
| 2025 | 1 | 1 | None | $75 |
| 2022 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Winrevair | $75 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Meals · 2025-03-20 | Winrevair | $75 |
See earlier years (2022)
2022: $20
| Boehringer Ingelheim Pharmaceuticals | Ofev | $20 | 1 payment
|
Professional record
- NPI
- 1164789772
- Licence
- PA MD459865
- Trained
- Johns Hopkins University School of Medicine, 2014
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 833 Chestnut St Ste 701, Philadelphia, PA, 19107
- NPI first listed
- 2012-04-19
- NPI last updated
- 2022-08-05
- NPI record certified
- 2022-08-05
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.